Search

everythinglearnresearchcommunity

for

Search:↓

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Activins and follistatins, part of the TGFβ family, are crucial for hair follicle development and skin health, affecting growth, repair, and the hair cycle.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Platelet-released growth factors can reduce inflammation in joint disease.

Finasteride reduces inflammation and improves immune response after trauma by altering hormone levels.

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Farudodstat may effectively treat alopecia areata without harmful side effects.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

Collagen VII helps skin heal and stay strong, sirolimus may lower skin cancer risk in kidney transplant patients, high-molecular-mass hyaluronan helps naked mole rats resist cancer, dermal γδ T cells aid in hair growth in rodents, and overexpression of IL-33 in mouse skin causes itchiness, offering a model for studying allergic inflammation treatments.

New treatments for male hair loss show promise but need more research for safety and effectiveness.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Chinese patients with alopecia areata value JAK inhibitors but worry about side effects and relapse, highlighting the need for education and support.

JAK inhibitors help regrow hair in alopecia areata, but their long-term safety is still unclear.

The immune system plays a key role in tissue repair, affecting both healing quality and regenerative ability.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

A mother's PPARγ is crucial for preventing harmful milk that can cause inflammation and growth problems in babies.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

An 81-year-old man's white hair began to regain its original color while he was treated with lenalidomide, suggesting that graying hair might be reversible.

Apremilast did not work for treating severe alopecia areata.

Platelet-Rich Plasma (PRP) could potentially help regrow hair in people with Alopecia Areata, but more research is needed to confirm its effectiveness.

Interleukin‐1 α reduces androgen receptor levels and increases certain cytokines in human scalp cells.

Skin conditions can signal heart issues, highlighting the need for integrated care.

Lower growth factors linked to balding in androgenetic alopecia.